Rolf Urbanus

Associate professor

University Medical Center Groningen

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Immunology Immunology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Rolf Urbanus is an Associate Professor at the University Medical Center Utrecht in the Netherlands. His research primarily focuses on hematology, with recent articles exploring topics such as venous thromboembolism, platelet disorders, and the implications of antibodies in bleeding disorders. His work contributes significantly to understanding platelet function and developing therapeutic strategies for inherited bleeding disorders.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (7)

Ruben Bierings

NETHERLANDS

View details

Albert Huisman

University Medical Center Groningen

NETHERLANDS

View details

Frank Leebeek

Erasmus University Rotterdam

NETHERLANDS

View details

Coen Maas

Associate professor

University Medical Center Groningen

NETHERLANDS

View details

Karin van Galen

University Medical Center Utrecht, Utrecht University

NETHERLANDS

View details

Roger Schutgens

Head of department, professor of Thrombosis and Haemostasis

University Medical Center Groningen

NETHERLANDS

View details

Moniek de Maat

Professor of Biochemistry of Haemostasis and Thrombosis

Erasmus MC

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Rolf Urbanus

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Proteomic analysis indicates lower abundance of platelet α-granule proteins in Glanzmann thrombasthenia

A rapid whole-blood adenosine triphosphate secretion test can be used to exclude platelet-dense granule deficiency

Elevated levels of (active) von Willebrand factor during anticoagulation are associated with early recurrence of venous thromboembolism

No correlation between thrombin generation and emicizumab levels: implications for monitoring emicizumab therapy

Limited value of testing for factor XIII and α2‐antiplasmin deficiency in patients with a bleeding disorder of unknown cause

Functional characterization of a nanobody-based glycoprotein VI-specific platelet agonist

“Antiphospholipid antibody solid phase–based assays: problems and proposed solutions for the 2023 ACR/EULAR classification criteria for antiphospholipid syndrome”: reply

A bispecific antibody approach for the potential prophylactic treatment of inherited bleeding disorders

Antiphospholipid antibody solid phase–based assays: problems and proposed solutions for the 2023 ACR/EULAR classification criteria for antiphospholipid syndrome

Identification of thrombosis-related conformational binding epitopes on domain I of β2-glycoprotein I

Acquired blood platelet disorder in patients with end-stage heart failure after implantation of a continuous centrifugal-flow left ventricular assist device: A prospective cohort study

Evaluation of the procoagulant state in chronic immune thrombocytopenia before and after eltrombopag treatment—a prospective cohort study

Insights in the Prothrombotic Changes after Implantation of a Left Ventricular Assist Device in Patients with End-Stage Heart Failure: A Longitudinal Observational Study

Interference in point-of-care international normalized ratio monitoring in patients with lupus anticoagulant is correlated with anti–β2-glycoprotein I antibody titers

Enhanced hepatic clearance of hyposialylated platelets explains thrombocytopenia in GNE-related macrothrombocytopenia

Flow Cytometry Based Platelet Reactivity Testing to Predict the Occurrence of Per-operative Solid Microemboli During Carotid Endarterectomy

Lupus anticoagulant associates with thrombosis in patients with COVID-19 admitted to intensive care units: A retrospective cohort study

Microlyse: a thrombolytic agent that targets VWF for clearance of microvascular thrombosis

Nanobodies against factor XI apple 3 domain inhibit binding of factor IX and reveal a novel binding site for high molecular weight kininogen

Platelet Activation via Glycoprotein VI Initiates Thrombin Generation: A Potential Role for Platelet-Derived Factor IX?

Collaborators (7)

Ruben Bierings

Albert Huisman

Frank Leebeek

Coen Maas

Karin van Galen

Roger Schutgens

Moniek de Maat

Make your next move.